Skip to content

Review, 2012

How is PMS diagnosed and treated, especially in women approaching menopause?

PMS affects 30-40% of reproductive-age women and responds to medications that suppress ovulation or SSRIs. Treatment must be customized to each woman's needs for contraception, PMS control, and symptom relief during the transition to menopause.

Strong study design Review article - not a primary study

What they did

This is a literature review focusing on PMS diagnosis and treatment, with particular attention to women in the peri-menopausal transition (approaching menopause).

What they found

PMS affects 30-40% of the reproductive female population and creates significant economic impact. Treatment should suppress ovulation via the hypothalamic-pituitary-ovarian axis or use selective serotonin reuptake inhibitors (SSRIs) because neurotransmitters are involved in reducing sensitivity to progesterone. Surgical methods are strongly discouraged and are a last resort. In peri-menopausal women, treatment must address contraceptive requirements, PMS control, and menopausal symptoms simultaneously.

What it means for you

PMS is common and treatable, but finding the right approach requires careful consideration of each woman's individual needs and life stage. The challenge in peri-menopause is balancing multiple health concerns at once.

30-40%

percentage of reproductive-age women affected by PMS

About the study

Original title
Premenstrual syndrome (PMS): a peri-menopausal perspective
Authors
Baker LJ, O'Brien PM
Journal
Maturitas
Year
2012
Study design
Review
What was tested
Review article

Topics